Ottawa Public Health is warning of an increased overdose risk after a highly potent synthetic opioid was detected in counterfeit pills in the city’s unregulated drug supply. The pills were stamped “M30” and closely resembled oxycodone tablets, raising concerns that people could unknowingly take a much stronger substance.
According to reporting by CBC Ottawa’s Liam Baker, the health unit said in a Tuesday release that Health Canada had detected protonitazepyne earlier that week. The substance belongs to a class of synthetic opioids called nitazenes. OPH estimates it is roughly 25 times more potent than fentanyl and 350 times more potent than morphine.
The health unit says protonitazepyne can cause fatal respiratory depression and its potency can make overdoses difficult to treat. Multiple doses of naloxone are typically required to counteract overdoses involving the drug, according to OPH.
Rob Boyd, CEO of Ottawa Inner City Health, told CBC that counterfeit pills can create dangerous expectations about what someone is taking and how strong it will be.
Boyd also raised concerns about gaps in local drug monitoring following the closure of Ottawa’s last supervised consumption sites in June, after provincial funding cuts. He said those sites provided drug-testing services that could have helped identify the substance sooner.
“We’re really flying blind right now. We don’t have that same access to what’s coming into the site,” Boyd told CBC.
Boyd estimated that protonitazepyne may have been circulating locally for three weeks before the alert. That remains his estimate, rather than a confirmed timeline of the drug’s presence in Ottawa.
Dr. Hawre Jalal, an associate professor at the University of Ottawa’s school of epidemiology and public health, cautioned that neither a pill’s appearance nor commonly used drug-testing methods can reliably establish whether it contains nitazenes.
“You cannot rely on just the physical visual confirmation of what the pill is to know what is actually inside the pill,” Jalal told CBC.
Jalal said greater awareness, naloxone distribution and expanded drug testing could help address the local risk. CBC reported that drug-checking services remain available at the Sandy Hill Community Health Centre in Ottawa.



Leave a comment
Join the discussion. Please follow our Community Standards.
Sign in or create an account to leave a comment.
Choose your public display name before submitting. Your email address stays private.
No published comments yet.